[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:adamantinomatous-craniopharyngioma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":29,"states":30},"Adamantinomatous Craniopharyngioma",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05286788","MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma",[12],"Phase 2","RECRUITING","2026-08-26T02:18:54.586325Z","2026-05-05T02:43:29.392585Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05233397","ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma",[12],"2026-08-26T02:18:20.384845Z","2026-05-05T02:43:27.313662Z",{"nct_id":23,"title":24,"phases":25,"status":26,"updated_at":27,"content_modified":28},"NCT03610906","Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:59.895916Z","2026-06-16T05:54:07.967963Z",[],[31],{"state":32,"count":5,"slug":33},"Colorado","colorado"]